The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study

被引:20
作者
Hermans, Sabine M. [1 ,2 ,3 ,4 ]
Grant, Alison D. [1 ,5 ,6 ]
Chihota, Violet [5 ,7 ]
Lewis, James J. [1 ]
Vynnycky, Emilia [1 ,8 ]
Churchyard, Gavin J. [1 ,5 ,7 ,9 ]
Fielding, Katherine L. [1 ,5 ]
机构
[1] London Sch Hyg & Trop Med, TB Ctr, London WC1, England
[2] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa
[4] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Internal Med, Kampala, Uganda
[5] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa
[6] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Africa Ctr Populat Hlth, Durban, South Africa
[7] Aurum Inst, Johannesburg, South Africa
[8] Publ Hlth England, London, England
[9] MRC Collaborating Ctr Excellence, Advancing Care & Treatment TB & HIV, Johannesburg, South Africa
来源
BMC MEDICINE | 2016年 / 14卷
基金
瑞士国家科学基金会; 比尔及梅琳达.盖茨基金会;
关键词
Isoniazid preventive therapy; Latent infection; Reactivation; Reinfection; Tuberculosis; HIV-INFECTED ADULTS; RECURRENT TUBERCULOSIS; REINFECTION TUBERCULOSIS; ANTIRETROVIRAL THERAPY; ACTIVE TUBERCULOSIS; DOUBLE-BLIND; TRIAL; RISK; PROPHYLAXIS; POPULATION;
D O I
10.1186/s12916-016-0589-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The durability of isoniazid preventive therapy (IPT) in preventing tuberculosis (TB) is limited in high-prevalence settings. The underlying mechanism (reactivation of persistent latent TB or reinfection) is not known. We aimed to investigate the timing of TB incidence during and after IPT and associated risk factors in a very high TB and HIV-prevalence setting, and to compare the observed rate with a modelled estimate of TB incidence rate after IPT due to reinfection. Methods: In a post-hoc analysis of a cluster-randomized trial of community-wide IPT among South African gold miners, all intervention arm participants that were dispensed IPT for at least one of the intended 9 months were included. An incident TB case was defined as any participant with a positive sputum smear or culture, or with a clinical TB diagnosis assigned by a senior study clinician. Crude TB incidence rates were calculated during and after IPT, overall and by follow-up time. HIV status was not available. Multivariable Cox regression was used to analyse risk factors by follow-up time after IPT. Estimates from a published mathematical model of trial data were used to calculate the average reinfection TB incidence in the first year after IPT. Results: Among 18,520 participants (96 % male, mean age 41 years, median follow-up 2.1 years), 708 developed TB. The TB incidence rate during the intended IPT period was 1.3/100 person-years (pyrs; 95 % confidence interval (CI), 1.0-1.6) and afterwards 2.3/100 pyrs (95 % CI, 1.9-2.7). TB incidence increased within 6 months followed by a stable rate over time. There was no evidence for changing risk factors for TB disease over time after miners stopped IPT. The average TB incidence rate attributable to reinfection in the first year was estimated at 1.3/100 pyrs, compared to an observed rate of 2.2/100 pyrs (95 % CI, 1.8-2.7). Conclusions: The durability of protection by IPT was lost within 6-12 months in this setting with a high HIV prevalence and a high annual risk of M. tuberculosis infection. The observed rate was higher than the modelled rate, suggesting that reactivation of persistent latent infection played a role in the rapid return to baseline TB incidence.
引用
收藏
页数:11
相关论文
共 50 条
[41]   The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study [J].
Assebe, Lelisa Fekadu ;
Reda, Hailemariam Lemma ;
Wubeneh, Alem Desta ;
Lerebo, Wondwossen Terefe ;
Lambert, Saba Maria .
BMC PUBLIC HEALTH, 2015, 15
[42]   Effect of isoniazid preventive therapy on pulmonary tuberculosis activity in people living with HIV/AIDS at Wangaya hospital in Denpasar, Bali, Indonesia: A prospective cohort study [J].
Suryana, Ketut ;
Suharsono, Hamong ;
Antara, Jarwa ;
Rai, Ida Bagus Ngurah .
BALI MEDICAL JOURNAL, 2020, 9 (01) :219-223
[43]   Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study [J].
Grace A. Shayo ;
Dereck Chitama ;
Candida Moshiro ;
Said Aboud ;
Muhammad Bakari ;
Ferdinand Mugusi .
BMC Public Health, 18
[44]   Challenges to delivery of isoniazid preventive therapy in a cohort of children exposed to tuberculosis in Timor-Leste [J].
Hall, Charlotte ;
Sukijthamapan, P. ;
dos Santos, R. ;
Nourse, C. ;
Murphy, D. ;
Gibbons, M. ;
Francis, J. R. .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 (06) :730-736
[45]   Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults [J].
Moh, R. ;
Badje, A. ;
N'takpe, J-B. ;
Kouame, G. M. ;
Gabillard, D. ;
Ouassa, T. ;
Ouattara, E. ;
Le Carrou, J. ;
Bohoussou, F. ;
Messou, E. ;
Eholie, S. ;
Anglaret, X. ;
Danel, C. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2017, 21 (12) :1237-+
[46]   Long-term Protection From Isoniazid Preventive Therapy for Tuberculosis in HIV-Infected Patients in a Medium-Burden Tuberculosis Setting: The TB/HIV in Rio (THRio) Study [J].
Golub, Jonathan E. ;
Cohn, Silvia ;
Saraceni, Valeria ;
Cavalcante, Solange C. ;
Pacheco, Antonio G. ;
Moulton, Lawrence H. ;
Durovni, Betina ;
Chaisson, Richard E. .
CLINICAL INFECTIOUS DISEASES, 2015, 60 (04) :639-645
[47]   Short-course untargeted isoniazid preventive therapy in South Africa: time to rethink policy? [J].
Lawn, Stephen D. ;
Wood, Robin .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (08) :995-996
[48]   Inequality in uptake of isoniazid prevention therapy and Mantoux test among pregnant women with HIV in the Eastern Cape, South Africa [J].
Adeniyi, Oladele Vincent ;
Selanto-Chairman, Nonkosi ;
Owolabi, Eyitayo Omolara ;
Ajayi, Anthony Idowu ;
Kayembe, Dominique Kabengele ;
Ter Goon, Daniel ;
Gordana, Avramovic ;
Lambert, John .
BMC PUBLIC HEALTH, 2019, 19 (01)
[49]   Trends in silicosis prevalence and the healthy worker effect among gold miners in South Africa: a prevalence study with follow up of employment status [J].
Knight, David ;
Ehrlich, Rodney ;
Fielding, Katherine ;
Jeffery, Hannah ;
Grant, Alison ;
Churchyard, Gavin .
BMC PUBLIC HEALTH, 2015, 15
[50]   The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis [J].
Geremew, Demeke ;
Endalamaw, Aklilu ;
Negash, Markos ;
Eshetie, Setegn ;
Tessema, Belay .
BMC INFECTIOUS DISEASES, 2019, 19 (1)